Biological Information

Family:

Oncology

Organism:

Human

Construct Details:

Endogenous

Cell Type:

PLC/PRF/5

Assay Information

Assay Type:

Functional

Assay Sub Type:

Cell Based

Functional Mode:

Antagonist

Detection Method:

Luminescence

Measured Response:

Luminescence

Testing Information

Procedure Summary:

Human liver hepatoma PLC/PRF/5 cells (ATCC, CRL-8024), (3 x 10^4/ml in growth medium), are pre-incubated in 96-well plates in an atmosphere of 5% CO2 at 37°C overnight. Test compound and/or vehicle is then added for an additional 72 hours. After the 72-hour incubation, CellTiter-Glo reagent is added and for a 10 minute incubation luminescence is measured using a microplate reader. Growth inhibition (GI50), total growth inhibition (TGI) and the 50% lethal concentration (LC50) are reported.

Incubation:

3 d at 37°C

Control Inhibitor:

Staurosporine

Criteria For Significance:

≤ 50% Cell Growth

Test Concentration / Dose:

Compounds are screened at 30, 10, 3, 1, 0.3, 0.1, 0.03 and 0.01 μM

Test Sample Requirements:

75 μl of 10 mM stock or 1 mg (pre-weighed) powder (assuming FW ≦500 and purity 100%)

Minimum Order Quantity:

16

Turnaround Time

Standard:

20 Business Days

Reference Compound Data

PubChem ID

5746

Name

Mitomycin C

Measurement

0.56μM - IC50

PubChem ID

31703

Name

Doxorubicin

Measurement

0.02μM - IC50

PubChem ID

122130844

Name

Staurosporine

Measurement

0.018μM - IC50

Clinical Relevance

Therapeutic Area:

Oncology/Immuno-Oncology

Additional Information

Brand:

Panlabs

Testing Location:

Taiwan - Taipei